Stetson Hatter Angel Network Invests in AI
Stetson University’s Hatter Angel Network, a group of accredited investors comprised of Stetson University alumni and faculty, recently invested $135,000 in EVQLV, a biotechnology company that harnesses the power of artificial intelligence (AI) to accelerate drug discovery and development, according to a media release.
As with all Hatter Angel Network investments, the opportunity was first vetted by students as a class project and then pitched to the investors. The investment is part of a larger funding round that EVQLV has secured to further develop its AI-driven platform, which streamlines the drug-discovery process by predicting and optimizing the properties of therapeutic antibodies. With this investment, EVQLV plans to expand its team and bolster its infrastructure to continue delivering innovative solutions to the biotech industry.
“We are thrilled to support EVQLV’s groundbreaking work in the field of biotechnology,” said Dan Glunt, cofounder of the Hatter Angel Network who also is a Stetson University Entrepreneurship Advisory Board member and a 1993 Stetson alumnus, in the release.
Founded in 2018 by a team of experts in AI, biotechnology and drug discovery, EVQLV is a leading player in the biotech industry and its platform has been adopted by major pharmaceutical companies to speed the discovery and development of new treatments for diseases such as cancer and COVID-19, the release states.
“Stetson University’s Hatter Angel Network investment in EVQLV is a testament to the potential of our platform to revolutionize the biotech industry,” said Andrew Satz, CEO and co-founder of EVQLV, in the release. “We feel very fortunate to have Hatter Angels as part of the company and joining us on this journey. Their support will help us accelerate our growth and continue to drive innovation in drug development.”
The Hatter Angel Network was formed in 2019 and serves as a financial backing to leverage the recommendations of Stetson entrepreneurship students and provide real-world experience with actual investments in emerging companies. The organization primarily invests in Florida-based companies.
